Global Duchenne Muscular Dystrophy Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. DMD is caused due to alteration in gene sequence coding for dystrophin protein, which is present the muscle. Duchenne muscular dystrophy (DMD) drugs are drugs used for treatment of Duchenne muscular dystrophy (DMD) disease, which include three approved products: Exondys51, Translarna and Emflaza.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Duchenne Muscular Dystrophy Drugs market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Duchenne Muscular Dystrophy Drugs market are covered in Chapter 9:
Eli Lilly
Pfizer
Acceleron Pharma
Nobelpharma
Bristol-Myers Squibb
Lexicon Pharmaceuticals
Marathon Pharmaceuticals
Catabasis Pharmaceuticals
Capricor Therapeutics
Akashi Therapeutics
Asklepios BioPharmaceuticals
Summit Therapeutics
Sarepta Therapeutics
Santhera Pharmaceuticals
Taiho Pharmaceutical
BioMarin Pharmaceutical
Janssen Pharmaceuticals
PTC Therapeutics
Italfarmaco
Nippon Shinyaku
In Chapter 5 and Chapter 7.3, based on types, the Duchenne Muscular Dystrophy Drugs market from 2017 to 2027 is primarily split into:
Exondys51
Translarna
Emflaza
In Chapter 6 and Chapter 7.4, based on applications, the Duchenne Muscular Dystrophy Drugs market from 2017 to 2027 covers:
Hospitals
Home care settings
Clinics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Duchenne Muscular Dystrophy Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Duchenne Muscular Dystrophy Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 DUCHENNE MUSCULAR DYSTROPHY DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Duchenne Muscular Dystrophy Drugs Market
1.2 Duchenne Muscular Dystrophy Drugs Market Segment by Type
1.2.1 Global Duchenne Muscular Dystrophy Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Duchenne Muscular Dystrophy Drugs Market Segment by Application
1.3.1 Duchenne Muscular Dystrophy Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Duchenne Muscular Dystrophy Drugs Market, Region Wise (2017-2027)
1.4.1 Global Duchenne Muscular Dystrophy Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.4 China Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.6 India Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Duchenne Muscular Dystrophy Drugs (2017-2027)
1.5.1 Global Duchenne Muscular Dystrophy Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Duchenne Muscular Dystrophy Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Duchenne Muscular Dystrophy Drugs Market
2 INDUSTRY OUTLOOK
2.1 Duchenne Muscular Dystrophy Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Duchenne Muscular Dystrophy Drugs Market Drivers Analysis
2.4 Duchenne Muscular Dystrophy Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Duchenne Muscular Dystrophy Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Duchenne Muscular Dystrophy Drugs Industry Development
3 GLOBAL DUCHENNE MUSCULAR DYSTROPHY DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Duchenne Muscular Dystrophy Drugs Average Price by Player (2017-2022)
3.4 Global Duchenne Muscular Dystrophy Drugs Gross Margin by Player (2017-2022)
3.5 Duchenne Muscular Dystrophy Drugs Market Competitive Situation and Trends
3.5.1 Duchenne Muscular Dystrophy Drugs Market Concentration Rate
3.5.2 Duchenne Muscular Dystrophy Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL DUCHENNE MUSCULAR DYSTROPHY DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.5 Europe Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.6 China Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.7 Japan Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.8 India Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.9 Southeast Asia Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.10 Latin America Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.11 Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Under COVID-19
5 GLOBAL DUCHENNE MUSCULAR DYSTROPHY DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Duchenne Muscular Dystrophy Drugs Price by Type (2017-2022)
5.4 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue and Growth Rate of Exondys51 (2017-2022)
5.4.2 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue and Growth Rate of Translarna (2017-2022)
5.4.3 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue and Growth Rate of Emflaza (2017-2022)
6 GLOBAL DUCHENNE MUSCULAR DYSTROPHY DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Duchenne Muscular Dystrophy Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Duchenne Muscular Dystrophy Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Home care settings (2017-2022)
6.3.3 Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Clinics (2017-2022)
7 GLOBAL DUCHENNE MUSCULAR DYSTROPHY DRUGS MARKET FORECAST (2022-2027)
7.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Duchenne Muscular Dystrophy Drugs Price and Trend Forecast (2022-2027)
7.2 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Duchenne Muscular Dystrophy Drugs Revenue and Growth Rate of Exondys51 (2022-2027)
7.3.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Growth Rate of Translarna (2022-2027)
7.3.3 Global Duchenne Muscular Dystrophy Drugs Revenue and Growth Rate of Emflaza (2022-2027)
7.4 Global Duchenne Muscular Dystrophy Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Duchenne Muscular Dystrophy Drugs Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Duchenne Muscular Dystrophy Drugs Consumption Value and Growth Rate of Home care settings(2022-2027)
7.4.3 Global Duchenne Muscular Dystrophy Drugs Consumption Value and Growth Rate of Clinics(2022-2027)
7.5 Duchenne Muscular Dystrophy Drugs Market Forecast Under COVID-19
8 DUCHENNE MUSCULAR DYSTROPHY DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Duchenne Muscular Dystrophy Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Duchenne Muscular Dystrophy Drugs Analysis
8.6 Major Downstream Buyers of Duchenne Muscular Dystrophy Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Duchenne Muscular Dystrophy Drugs Industry
9 PLAYERS PROFILES
9.1 Eli Lilly
9.1.1 Eli Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.1.3 Eli Lilly Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Pfizer
9.2.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.2.3 Pfizer Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Acceleron Pharma
9.3.1 Acceleron Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.3.3 Acceleron Pharma Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Nobelpharma
9.4.1 Nobelpharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.4.3 Nobelpharma Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Bristol-Myers Squibb
9.5.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.5.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Lexicon Pharmaceuticals
9.6.1 Lexicon Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.6.3 Lexicon Pharmaceuticals Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Marathon Pharmaceuticals
9.7.1 Marathon Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.7.3 Marathon Pharmaceuticals Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Catabasis Pharmaceuticals
9.8.1 Catabasis Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.8.3 Catabasis Pharmaceuticals Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Capricor Therapeutics
9.9.1 Capricor Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.9.3 Capricor Therapeutics Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Akashi Therapeutics
9.10.1 Akashi Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.10.3 Akashi Therapeutics Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Asklepios BioPharmaceuticals
9.11.1 Asklepios BioPharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.11.3 Asklepios BioPharmaceuticals Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Summit Therapeutics
9.12.1 Summit Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.12.3 Summit Therapeutics Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Sarepta Therapeutics
9.13.1 Sarepta Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.13.3 Sarepta Therapeutics Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Santhera Pharmaceuticals
9.14.1 Santhera Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.14.3 Santhera Pharmaceuticals Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Taiho Pharmaceutical
9.15.1 Taiho Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.15.3 Taiho Pharmaceutical Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 BioMarin Pharmaceutical
9.16.1 BioMarin Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.16.3 BioMarin Pharmaceutical Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Janssen Pharmaceuticals
9.17.1 Janssen Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.17.3 Janssen Pharmaceuticals Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 PTC Therapeutics
9.18.1 PTC Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.18.3 PTC Therapeutics Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 Italfarmaco
9.19.1 Italfarmaco Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.19.3 Italfarmaco Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Nippon Shinyaku
9.20.1 Nippon Shinyaku Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.20.3 Nippon Shinyaku Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Duchenne Muscular Dystrophy Drugs Market
1.2 Duchenne Muscular Dystrophy Drugs Market Segment by Type
1.2.1 Global Duchenne Muscular Dystrophy Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Duchenne Muscular Dystrophy Drugs Market Segment by Application
1.3.1 Duchenne Muscular Dystrophy Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Duchenne Muscular Dystrophy Drugs Market, Region Wise (2017-2027)
1.4.1 Global Duchenne Muscular Dystrophy Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.4 China Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.6 India Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Duchenne Muscular Dystrophy Drugs (2017-2027)
1.5.1 Global Duchenne Muscular Dystrophy Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Duchenne Muscular Dystrophy Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Duchenne Muscular Dystrophy Drugs Market
2 INDUSTRY OUTLOOK
2.1 Duchenne Muscular Dystrophy Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Duchenne Muscular Dystrophy Drugs Market Drivers Analysis
2.4 Duchenne Muscular Dystrophy Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Duchenne Muscular Dystrophy Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Duchenne Muscular Dystrophy Drugs Industry Development
3 GLOBAL DUCHENNE MUSCULAR DYSTROPHY DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Duchenne Muscular Dystrophy Drugs Average Price by Player (2017-2022)
3.4 Global Duchenne Muscular Dystrophy Drugs Gross Margin by Player (2017-2022)
3.5 Duchenne Muscular Dystrophy Drugs Market Competitive Situation and Trends
3.5.1 Duchenne Muscular Dystrophy Drugs Market Concentration Rate
3.5.2 Duchenne Muscular Dystrophy Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL DUCHENNE MUSCULAR DYSTROPHY DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.5 Europe Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.6 China Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.7 Japan Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.8 India Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.9 Southeast Asia Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.10 Latin America Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Duchenne Muscular Dystrophy Drugs Market Under COVID-19
4.11 Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Under COVID-19
5 GLOBAL DUCHENNE MUSCULAR DYSTROPHY DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Duchenne Muscular Dystrophy Drugs Price by Type (2017-2022)
5.4 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue and Growth Rate of Exondys51 (2017-2022)
5.4.2 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue and Growth Rate of Translarna (2017-2022)
5.4.3 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue and Growth Rate of Emflaza (2017-2022)
6 GLOBAL DUCHENNE MUSCULAR DYSTROPHY DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Duchenne Muscular Dystrophy Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Duchenne Muscular Dystrophy Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Hospitals (2017-2022)
6.3.2 Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Home care settings (2017-2022)
6.3.3 Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Clinics (2017-2022)
7 GLOBAL DUCHENNE MUSCULAR DYSTROPHY DRUGS MARKET FORECAST (2022-2027)
7.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Duchenne Muscular Dystrophy Drugs Price and Trend Forecast (2022-2027)
7.2 Global Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Duchenne Muscular Dystrophy Drugs Revenue and Growth Rate of Exondys51 (2022-2027)
7.3.2 Global Duchenne Muscular Dystrophy Drugs Revenue and Growth Rate of Translarna (2022-2027)
7.3.3 Global Duchenne Muscular Dystrophy Drugs Revenue and Growth Rate of Emflaza (2022-2027)
7.4 Global Duchenne Muscular Dystrophy Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Duchenne Muscular Dystrophy Drugs Consumption Value and Growth Rate of Hospitals(2022-2027)
7.4.2 Global Duchenne Muscular Dystrophy Drugs Consumption Value and Growth Rate of Home care settings(2022-2027)
7.4.3 Global Duchenne Muscular Dystrophy Drugs Consumption Value and Growth Rate of Clinics(2022-2027)
7.5 Duchenne Muscular Dystrophy Drugs Market Forecast Under COVID-19
8 DUCHENNE MUSCULAR DYSTROPHY DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Duchenne Muscular Dystrophy Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Duchenne Muscular Dystrophy Drugs Analysis
8.6 Major Downstream Buyers of Duchenne Muscular Dystrophy Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Duchenne Muscular Dystrophy Drugs Industry
9 PLAYERS PROFILES
9.1 Eli Lilly
9.1.1 Eli Lilly Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.1.3 Eli Lilly Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Pfizer
9.2.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.2.3 Pfizer Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Acceleron Pharma
9.3.1 Acceleron Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.3.3 Acceleron Pharma Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Nobelpharma
9.4.1 Nobelpharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.4.3 Nobelpharma Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Bristol-Myers Squibb
9.5.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.5.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Lexicon Pharmaceuticals
9.6.1 Lexicon Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.6.3 Lexicon Pharmaceuticals Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Marathon Pharmaceuticals
9.7.1 Marathon Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.7.3 Marathon Pharmaceuticals Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Catabasis Pharmaceuticals
9.8.1 Catabasis Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.8.3 Catabasis Pharmaceuticals Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Capricor Therapeutics
9.9.1 Capricor Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.9.3 Capricor Therapeutics Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Akashi Therapeutics
9.10.1 Akashi Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.10.3 Akashi Therapeutics Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Asklepios BioPharmaceuticals
9.11.1 Asklepios BioPharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.11.3 Asklepios BioPharmaceuticals Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Summit Therapeutics
9.12.1 Summit Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.12.3 Summit Therapeutics Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Sarepta Therapeutics
9.13.1 Sarepta Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.13.3 Sarepta Therapeutics Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Santhera Pharmaceuticals
9.14.1 Santhera Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.14.3 Santhera Pharmaceuticals Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Taiho Pharmaceutical
9.15.1 Taiho Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.15.3 Taiho Pharmaceutical Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 BioMarin Pharmaceutical
9.16.1 BioMarin Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.16.3 BioMarin Pharmaceutical Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Janssen Pharmaceuticals
9.17.1 Janssen Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.17.3 Janssen Pharmaceuticals Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
9.18 PTC Therapeutics
9.18.1 PTC Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.18.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.18.3 PTC Therapeutics Market Performance (2017-2022)
9.18.4 Recent Development
9.18.5 SWOT Analysis
9.19 Italfarmaco
9.19.1 Italfarmaco Basic Information, Manufacturing Base, Sales Region and Competitors
9.19.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.19.3 Italfarmaco Market Performance (2017-2022)
9.19.4 Recent Development
9.19.5 SWOT Analysis
9.20 Nippon Shinyaku
9.20.1 Nippon Shinyaku Basic Information, Manufacturing Base, Sales Region and Competitors
9.20.2 Duchenne Muscular Dystrophy Drugs Product Profiles, Application and Specification
9.20.3 Nippon Shinyaku Market Performance (2017-2022)
9.20.4 Recent Development
9.20.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Duchenne Muscular Dystrophy Drugs Product Picture
Table Global Duchenne Muscular Dystrophy Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Duchenne Muscular Dystrophy Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Duchenne Muscular Dystrophy Drugs Industry Development
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume by Player (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume Share by Player (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume Share by Player in 2021
Table Duchenne Muscular Dystrophy Drugs Revenue (Million USD) by Player (2017-2022)
Table Duchenne Muscular Dystrophy Drugs Revenue Market Share by Player (2017-2022)
Table Duchenne Muscular Dystrophy Drugs Price by Player (2017-2022)
Table Duchenne Muscular Dystrophy Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume, Region Wise (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, Region Wise in 2021
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume by Type (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share by Type in 2021
Table Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Type in 2021
Table Duchenne Muscular Dystrophy Drugs Price by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate of Exondys51 (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Exondys51 (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate of Translarna (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Translarna (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate of Emflaza (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Emflaza (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption Market Share by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Home care settings (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Clinics (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Price and Trend Forecast (2022-2027)
Figure USA Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Duchenne Muscular Dystrophy Drugs Market Sales Volume Forecast, by Type
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share Forecast, by Type
Table Global Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Duchenne Muscular Dystrophy Drugs Revenue Market Share Forecast, by Type
Table Global Duchenne Muscular Dystrophy Drugs Price Forecast, by Type
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Exondys51 (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Exondys51 (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Translarna (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Translarna (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Emflaza (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Emflaza (2022-2027)
Table Global Duchenne Muscular Dystrophy Drugs Market Consumption Forecast, by Application
Table Global Duchenne Muscular Dystrophy Drugs Consumption Market Share Forecast, by Application
Table Global Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Duchenne Muscular Dystrophy Drugs Revenue Market Share Forecast, by Application
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Value (Million USD) and Growth Rate of Home care settings (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Value (Million USD) and Growth Rate of Clinics (2022-2027)
Figure Duchenne Muscular Dystrophy Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Eli Lilly Profile
Table Eli Lilly Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Eli Lilly Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Acceleron Pharma Profile
Table Acceleron Pharma Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Acceleron Pharma Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Acceleron Pharma Revenue (Million USD) Market Share 2017-2022
Table Nobelpharma Profile
Table Nobelpharma Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nobelpharma Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Nobelpharma Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Table Lexicon Pharmaceuticals Profile
Table Lexicon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lexicon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Lexicon Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Marathon Pharmaceuticals Profile
Table Marathon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Marathon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Marathon Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Catabasis Pharmaceuticals Profile
Table Catabasis Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Catabasis Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Catabasis Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Capricor Therapeutics Profile
Table Capricor Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Capricor Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Capricor Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Akashi Therapeutics Profile
Table Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Akashi Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Asklepios BioPharmaceuticals Profile
Table Asklepios BioPharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Asklepios BioPharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Asklepios BioPharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Summit Therapeutics Profile
Table Summit Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Summit Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Summit Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Sarepta Therapeutics Profile
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Sarepta Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Santhera Pharmaceuticals Profile
Table Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Santhera Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Taiho Pharmaceutical Profile
Table Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Taiho Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table BioMarin Pharmaceutical Profile
Table BioMarin Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BioMarin Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure BioMarin Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Janssen Pharmaceuticals Profile
Table Janssen Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Janssen Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Janssen Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table PTC Therapeutics Profile
Table PTC Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PTC Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure PTC Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Italfarmaco Profile
Table Italfarmaco Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Italfarmaco Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Italfarmaco Revenue (Million USD) Market Share 2017-2022
Table Nippon Shinyaku Profile
Table Nippon Shinyaku Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nippon Shinyaku Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Nippon Shinyaku Revenue (Million USD) Market Share 2017-2022
Figure Duchenne Muscular Dystrophy Drugs Product Picture
Table Global Duchenne Muscular Dystrophy Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Duchenne Muscular Dystrophy Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Duchenne Muscular Dystrophy Drugs Industry Development
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume by Player (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume Share by Player (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume Share by Player in 2021
Table Duchenne Muscular Dystrophy Drugs Revenue (Million USD) by Player (2017-2022)
Table Duchenne Muscular Dystrophy Drugs Revenue Market Share by Player (2017-2022)
Table Duchenne Muscular Dystrophy Drugs Price by Player (2017-2022)
Table Duchenne Muscular Dystrophy Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume, Region Wise (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, Region Wise in 2021
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume by Type (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share by Type in 2021
Table Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue Market Share by Type in 2021
Table Duchenne Muscular Dystrophy Drugs Price by Type (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate of Exondys51 (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Exondys51 (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate of Translarna (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Translarna (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate of Emflaza (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Emflaza (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption Market Share by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Hospitals (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Home care settings (2017-2022)
Table Global Duchenne Muscular Dystrophy Drugs Consumption and Growth Rate of Clinics (2017-2022)
Figure Global Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Price and Trend Forecast (2022-2027)
Figure USA Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Duchenne Muscular Dystrophy Drugs Market Sales Volume Forecast, by Type
Table Global Duchenne Muscular Dystrophy Drugs Sales Volume Market Share Forecast, by Type
Table Global Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Duchenne Muscular Dystrophy Drugs Revenue Market Share Forecast, by Type
Table Global Duchenne Muscular Dystrophy Drugs Price Forecast, by Type
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Exondys51 (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Exondys51 (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Translarna (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Translarna (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Emflaza (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Revenue (Million USD) and Growth Rate of Emflaza (2022-2027)
Table Global Duchenne Muscular Dystrophy Drugs Market Consumption Forecast, by Application
Table Global Duchenne Muscular Dystrophy Drugs Consumption Market Share Forecast, by Application
Table Global Duchenne Muscular Dystrophy Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Duchenne Muscular Dystrophy Drugs Revenue Market Share Forecast, by Application
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Value (Million USD) and Growth Rate of Hospitals (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Value (Million USD) and Growth Rate of Home care settings (2022-2027)
Figure Global Duchenne Muscular Dystrophy Drugs Consumption Value (Million USD) and Growth Rate of Clinics (2022-2027)
Figure Duchenne Muscular Dystrophy Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Eli Lilly Profile
Table Eli Lilly Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eli Lilly Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Eli Lilly Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Acceleron Pharma Profile
Table Acceleron Pharma Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Acceleron Pharma Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Acceleron Pharma Revenue (Million USD) Market Share 2017-2022
Table Nobelpharma Profile
Table Nobelpharma Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nobelpharma Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Nobelpharma Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Table Lexicon Pharmaceuticals Profile
Table Lexicon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Lexicon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Lexicon Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Marathon Pharmaceuticals Profile
Table Marathon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Marathon Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Marathon Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Catabasis Pharmaceuticals Profile
Table Catabasis Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Catabasis Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Catabasis Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Capricor Therapeutics Profile
Table Capricor Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Capricor Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Capricor Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Akashi Therapeutics Profile
Table Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Akashi Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Asklepios BioPharmaceuticals Profile
Table Asklepios BioPharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Asklepios BioPharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Asklepios BioPharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Summit Therapeutics Profile
Table Summit Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Summit Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Summit Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Sarepta Therapeutics Profile
Table Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Sarepta Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Santhera Pharmaceuticals Profile
Table Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Santhera Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Taiho Pharmaceutical Profile
Table Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Taiho Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table BioMarin Pharmaceutical Profile
Table BioMarin Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure BioMarin Pharmaceutical Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure BioMarin Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Janssen Pharmaceuticals Profile
Table Janssen Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Janssen Pharmaceuticals Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Janssen Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table PTC Therapeutics Profile
Table PTC Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PTC Therapeutics Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure PTC Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Italfarmaco Profile
Table Italfarmaco Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Italfarmaco Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Italfarmaco Revenue (Million USD) Market Share 2017-2022
Table Nippon Shinyaku Profile
Table Nippon Shinyaku Duchenne Muscular Dystrophy Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nippon Shinyaku Duchenne Muscular Dystrophy Drugs Sales Volume and Growth Rate
Figure Nippon Shinyaku Revenue (Million USD) Market Share 2017-2022
